Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 7 of 423 for:    varicose veins

A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Royal Hobart Hospital.
Recruitment status was  Recruiting
Information provided by:
Royal Hobart Hospital Identifier:
First received: July 12, 2007
Last updated: March 15, 2010
Last verified: March 2010
To investigate whether Betadine can reduce infection rates and recurrence rates following varicose veins surgery in a randomized double blind placebo controlled study.

Condition Intervention Phase
Varicose Veins
Wound Infection
Drug: Betadine
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment
Official Title: A Randomised, Blinded Study to Assess the Effect of Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery

Resource links provided by NLM:

Further study details as provided by Royal Hobart Hospital:

Primary Outcome Measures:
  • groin wound infection [ Time Frame: Up to 6 weeks post operative ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • - groin recurrence of varicose veins [ Time Frame: Up to one year post operatively ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: June 2004
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Betadine
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients undergoing primary saphenofemoral ligation for varicose veins (can be combined with short saphenous surgery).

Exclusion Criteria:

  • Allergy to iodine
  • Redo groin dissections
  • Patients having multiple avulsions only or saphenopopliteal ligation only
  • Patients unable to return to outpatients for 6 weeks to undergo assessment with the wound care nurse
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00500669

Contact: Stuart Walker, MBBS 03 62227064

Australia, Tasmania
Royal Hobart Hospital Recruiting
Hobart, Tasmania, Australia, 7001
Contact: Stuart Walker   
Sponsors and Collaborators
Royal Hobart Hospital
Principal Investigator: Stuart Walker, MBBS Royal Hobart Hospital
  More Information

Responsible Party: Mr Stuart Walker, Royal Hobart Hospital Identifier: NCT00500669     History of Changes
Other Study ID Numbers: H0011 
Study First Received: July 12, 2007
Last Updated: March 15, 2010
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Royal Hobart Hospital:
Varicose veins
wound infection

Additional relevant MeSH terms:
Varicose Veins
Wounds and Injuries
Wound Infection
Disease Attributes
Pathologic Processes
Vascular Diseases
Cardiovascular Diseases
Anti-Infective Agents, Local
Anti-Infective Agents processed this record on October 26, 2016